111 related articles for article (PubMed ID: 2164309)
1. In vitro activity of cefonicid compared to other antibiotics against clinical bacterial isolates.
Verbist L; Verhaegen J
Acta Clin Belg; 1990; 45(2):113-9. PubMed ID: 2164309
[TBL] [Abstract][Full Text] [Related]
2. Cefonicid versus cefuroxime: an in vitro study of 1,000 Enterobacteriaceae.
Keness J; Efrati Z; Raz R
Chemotherapy; 1992; 38(1):14-6. PubMed ID: 1617998
[TBL] [Abstract][Full Text] [Related]
3. Cefonicid, a long acting cephalosporin: in vitro activity compared with three cephalosporins and gentamicin.
Hamilton-Miller JM; Patel R; Brumfitt W
Drugs Exp Clin Res; 1986; 12(11):861-9. PubMed ID: 3816503
[TBL] [Abstract][Full Text] [Related]
4. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
[TBL] [Abstract][Full Text] [Related]
5. In vitro experience with cefonicid.
Actor P
Rev Infect Dis; 1984; 6 Suppl 4():S783-90. PubMed ID: 6522920
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of second and third generation cephalosporins against ampicillin susceptible and resistant haemophilus influenzae.
Burns JL; Wong K; Smith AL
Infection; 1988; 16(5):293-6. PubMed ID: 3265130
[TBL] [Abstract][Full Text] [Related]
7. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
[TBL] [Abstract][Full Text] [Related]
8. Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.
Dabernat HJ; Delmas C
Rev Infect Dis; 1982; 4 Suppl():S401-5. PubMed ID: 6294790
[TBL] [Abstract][Full Text] [Related]
9. BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates.
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1988 Jan; 9(1):11-26. PubMed ID: 3259489
[TBL] [Abstract][Full Text] [Related]
10. Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.
Neu HC; Fu KP
Antimicrob Agents Chemother; 1978 Apr; 13(4):657-64. PubMed ID: 248268
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
12. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--II. Gram-negative bacteria].
Suzuki Y; Nishinari C; Endo H; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2003 Aug; 56(4):309-35. PubMed ID: 14567255
[TBL] [Abstract][Full Text] [Related]
13. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2000--II. Gram-negative bacteria].
Suzuki Y; Nishinari C; Endo H; Tamura C; Jinbo K; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Apr; 55(2):154-80. PubMed ID: 12071094
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the so-called basic cephalosporins using the serum bactericidal test].
Milatovic D; Voss A; Machka K; Braveny I
Med Klin (Munich); 1992 Feb; 87(2):58-62. PubMed ID: 1542283
[TBL] [Abstract][Full Text] [Related]
15. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
Tartaglione TA; Polk RE
Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304
[TBL] [Abstract][Full Text] [Related]
16. [In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].
Chanal M; Cluzel M; Sirot D; Joly B; Sirot J; Cluzel R
Pathol Biol (Paris); 1986 May; 34(5):385-9. PubMed ID: 3095773
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
Verbist L
Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Johnson DM; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):181-8. PubMed ID: 1396735
[TBL] [Abstract][Full Text] [Related]
19. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
Braveny I; Dickert H; Machka K
Infection; 1979; 7(5):231-6. PubMed ID: 389804
[TBL] [Abstract][Full Text] [Related]
20. The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.
Neu HC; Chin NX; Labthavikul P
Infection; 1985; 13(3):146-55. PubMed ID: 3928497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
